Humacyte, Inc. - COM (HUMA)

CUSIP: 44486Q103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
13,437,579
Share change
+2,956,573
Total reported value
$43,130,190
Put/Call ratio
129%
Price per share
$3.21
Number of holders
75
Value change
+$8,049,232
Number of buys
47
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 44486Q103?
CUSIP 44486Q103 identifies HUMA - Humacyte, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2022

As of 30 Jun 2022, Humacyte, Inc. - COM (HUMA) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,437,579 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., York Capital Management Global Advisors, LLC, UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, Prescott General Partners LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and LPL Financial LLC. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.